Merck cut a drug discovery cycle by 33% and ships compliant marketing 80% faster. Mastercard is rethinking fraud disputes.
Canadian banks posted strong quarterly earnings as investors weighed economic risks, rates and long-term growth concerns.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results